Binimetinib (Mektovi)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Binimetinib (Mektovi), covering 2021-08-17 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma [Phase 3]